一个常见的瘤在一个不常见的区域
Mohammed Riyas Ali1, Daphylla Shisha Phanbuh1, Ravi Meher1
1Department of Otorhinolaryngology, Maulana Azad Medical College and Lok Nayak Hospital, Delhi, New Delhi 110002 India.
概括
这项研究详细介绍了一种罕见的腺脂瘤病例,这是一种良性软组织瘤. 对这种具有挑战性的,生长缓慢的体质进行了成功的手术管理.
科学领域:
- 头部和部手术 头部和部手术
- 手术瘤学手术瘤学
- 病理学 病理学 病理学
背景情况:
- 脂瘤是常见的良性软组织瘤,通常呈现为缓慢生长的无痛结节.
- 虽然脂质瘤可以发生在任何地方,但它们很少在膜区域发现.
- 状脂瘤由于靠近面部神经及其分支而带来了手术挑战.
研究的目的:
- 报告一个罕见的乳腺瘤在腺的病例.
- 为了突出皮脂瘤的外科治疗方法.
- 讨论与切除唇瘤相关的挑战.
主要方法:
- 一个30岁的男性患者的病例报告.
- 在右侧腺 (5.0 x 3.0厘米) 中出现软质体的临床表现.
- 腹膜脂瘤的手术切除.
主要成果:
- 成功的手术切除了皮脂瘤.
- 患者的脂瘤是一种良性,缓慢生长的软组织瘤.
- 手术程序解决了瘤位置所带来的挑战.
结论:
- 口腔脂瘤虽然很少见,但需要仔细考虑手术.
- 手术切除是一种有效的治疗策略,用于皮脂瘤.
- 了解解剖学复杂性对于成功的唇瘤手术至关重要.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.2K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
